Gender

Patient injects Ozempic
#Gender #GLP-1 #Obesity #Olio Labs #Preclinical investigations #Weight loss

Study reveals insights into GLP-1 drug effectiveness across sexes 

A new study has uncovered fundamental sex-based differences in how weight loss medications interact with human biology, revealing why women experience more severe side effects from GLP-1 drugs such as Ozempic and Zepbound.  Founded by leading neuroscientists and computational biologists in 2023, Olio Labs uses a novel… Read More

#News

#Gender #Neuroscience #Precision medicine #Women’s Brain Foundation

The urgent need for sex and gender to be recognised in drug discovery

DDW Editor Reece Armstrong speaks to Dr Antonella Santuccione Chadha, CEO of the Women’s Brain Foundation (WBF) about the importance of sex and gender differences in drug discovery efforts. The topic of gender disparity is a prevailing issue in modern society and is something which has caused fierce debate across political… Read More

#Exclusive Content